ONC206 是一种 ONC201 的类似物,是一种多巴胺 D2- 样受体 (DRD2/3/4) 的选择性拮抗剂,其拮抗作用在纳摩尔级别。它具有广谱抗肿瘤活性。
产品描述
ONC206 is an analogue of TRAIL inducer ONC201 and is a selective antagonist of the D2-like dopamine receptors (DRD2/3/4) at nanomolar concentrations. ONC206 also has broad-spectrum anti-tumor activity.
体外活性
ONC206 (Oncoceutics) is an imipiridone with nanomolar potency and analogue of ONC201, a selective dopamine receptor D2 (DRD2) antagonist currently being investigated in phase II clinical trials for serous endometrial cancer (SEC).??ONC206 inhibited cellular proliferation in a dose-dependent manner and was more potent than ONC201 in the ARK1 (IC50 = 0.33 M vs. IC50 = 1.59uM) and SPEC-2 (IC50 = 0.24uM vs. IC50 = 0.81uM) cell lines.?Treatment with ONC206 resulted in induction of ROS production and reduction of mitochondrial membrane potential, accompanied by an increase in cleaved caspase-3 and caspase-9 activity (p0.01).?ONC206 also significantly inhibited cellular adhesion and migration in both cell lines (p0.01).?Pretreatment with the stress inhibitor N-acetylcysteine (NAC) significantly attenuated the efficacy of ONC206 on cell proliferation, ROS production and cellular invasion.?ONC206 demonstrates nanomolar potency for the inhibition of proliferation in SEC cells[3].
体内活性
ONC206 (100 mg/kg; p.o.; every 10 days) reduces obviously tumor growth inhibition[2].
Cas No.
1638178-87-6
分子式
C23H22F2N4O
分子量
408.44
储存和溶解度
DMSO:100 mg/mL (244.83 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years